Does PAPAVERINE Cause Mobility decreased? 50 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Mobility decreased have been filed in association with PAPAVERINE (Papaverine Hydrochloride). This represents 14.7% of all adverse event reports for PAPAVERINE.
50
Reports of Mobility decreased with PAPAVERINE
14.7%
of all PAPAVERINE reports
0
Deaths
49
Hospitalizations
How Dangerous Is Mobility decreased From PAPAVERINE?
Of the 50 reports, 49 (98.0%) required hospitalization, and 32 (64.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAPAVERINE. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does PAPAVERINE Cause?
Toxicity to various agents (165)
Drug abuse (123)
Depressed level of consciousness (63)
Hypotension (62)
Balance disorder (52)
Fall (52)
Cognitive disorder (51)
Drug interaction (51)
Pain (51)
Sedation complication (51)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PAPAVERINE Alternatives Have Lower Mobility decreased Risk?
PAPAVERINE vs PARACETAMOL
PAPAVERINE vs PARATHYROID HORMONE
PAPAVERINE vs PARECOXIB
PAPAVERINE vs PARICALCITOL
PAPAVERINE vs PARITAPREVIR